News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
314,579 Results
Type
Article (13872)
Company Profile (99)
Press Release (300599)
Multimedia
Podcasts (37)
Webinars (12)
Section
Business (87567)
Career Advice (329)
Deals (17159)
Drug Delivery (65)
Drug Development (31492)
Employer Resources (54)
FDA (7751)
Job Trends (7416)
News (144880)
Policy (11729)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (2)
Academia (1108)
Academic (1)
Accelerated approval (13)
Adcomms (2)
Allergies (67)
Alliances (25082)
ALS (82)
Alzheimer's disease (780)
Antibody-drug conjugate (ADC) (205)
Approvals (8145)
Artificial intelligence (300)
Autoimmune disease (90)
Automation (28)
Bankruptcy (86)
Best Places to Work (6435)
BIOSECURE Act (11)
Biosimilars (132)
Biotechnology (53)
Bladder cancer (87)
Brain cancer (17)
Breast cancer (347)
Cancer (2608)
Cardiovascular disease (245)
Career advice (298)
Career pathing (9)
CAR-T (141)
CDC (3)
Cell therapy (402)
Cervical cancer (22)
Clinical research (28759)
Collaboration (1212)
Compensation (460)
Complete response letters (16)
COVID-19 (1514)
CRISPR (62)
C-suite (575)
Cystic fibrosis (76)
Data (3434)
Denatured (25)
Depression (54)
Diabetes (274)
Diagnostics (3529)
Digital health (28)
Diversity (5)
Diversity, equity & inclusion (15)
Drug discovery (137)
Drug pricing (41)
Drug shortages (12)
Duchenne muscular dystrophy (99)
Earnings (32272)
Editorial (16)
Employer branding (10)
Employer resources (48)
Events (51430)
Executive appointments (644)
FDA (9663)
Fibrodysplasia Ossificans Progressiva (5)
Frontotemporal dementia (6)
Funding (799)
Gene editing (130)
Generative AI (26)
Gene therapy (311)
GLP-1 (459)
Government (1493)
Grass and pollen (5)
Guidances (253)
Healthcare (8403)
HIV (41)
Huntington's disease (11)
IgA nephropathy (56)
Immunology and inflammation (103)
Immuno-oncology (28)
Indications (76)
Infectious disease (1679)
Inflammatory bowel disease (102)
Inflation Reduction Act (1)
Influenza (76)
Intellectual property (155)
Interviews (41)
IPO (7894)
IRA (11)
Job creations (1331)
Job search strategy (269)
JPM (27)
Kidney cancer (6)
Labor market (27)
Layoffs (187)
Leadership (8)
Legal (1974)
Liver cancer (52)
Longevity (4)
Lung cancer (428)
Lymphoma (214)
Machine learning (19)
Management (15)
Manufacturing (534)
MASH (98)
Medical device (7258)
Medtech (7282)
Mergers & acquisitions (9949)
Metabolic disorders (631)
Multiple sclerosis (85)
NASH (11)
Neurodegenerative disease (148)
Neuropsychiatric disorders (27)
Neuroscience (1363)
Neurotech (1)
NextGen: Class of 2026 (2026)
Non-profit (1817)
Now hiring (22)
Obesity (253)
Opinion (85)
Ovarian cancer (84)
Pain (83)
Pancreatic cancer (101)
Parkinson's disease (130)
Partnered (21)
Patents (271)
Patient recruitment (273)
Peanut (28)
People (29904)
Pharmaceutical (30)
Pharmacy benefit managers (3)
Phase 1 (7190)
Phase 2 (11501)
Phase 3 (12236)
Pipeline (3226)
Policy (76)
Postmarket research (1032)
Preclinical (2571)
Press Release (55)
Prostate cancer (129)
Psychedelics (10)
Radiopharmaceuticals (163)
Rare diseases (420)
Real estate (2936)
Recruiting (22)
Regulatory (10725)
Reports (20)
Research institute (1140)
Resumes & cover letters (35)
Rett syndrome (15)
RNA editing (4)
RSV (47)
Schizophrenia (85)
Series A (122)
Series B (109)
Service/supplier (3)
Sickle cell disease (64)
Special edition (5)
Spinal muscular atrophy (97)
Sponsored (26)
Startups (1357)
Stomach cancer (9)
Supply chain (68)
Tariffs (23)
The Weekly (12)
Vaccines (597)
Venture capital (32)
Weight loss (137)
Women's health (45)
Worklife (2)
Date
Last 7 days (322)
Last 30 days (1167)
Last 365 days (17101)
2026 (1584)
2025 (17324)
2024 (18935)
2023 (20969)
2022 (30106)
2021 (31828)
2020 (29455)
2019 (21685)
2018 (16263)
2017 (15059)
2016 (14222)
2015 (16143)
2014 (11717)
2013 (9499)
2012 (10126)
2011 (9848)
2010 (8422)
Location
Africa (339)
Alabama (49)
Alaska (4)
Arizona (91)
Arkansas (6)
Asia (24257)
Australia (3942)
California (5606)
Canada (1617)
China (980)
Colorado (189)
Connecticut (240)
Delaware (235)
Europe (51344)
Florida (813)
Georgia (179)
Hawaii (3)
Idaho (18)
Illinois (430)
India (61)
Indiana (374)
Iowa (9)
Japan (379)
Kansas (46)
Kentucky (12)
Louisiana (11)
Maine (34)
Maryland (673)
Massachusetts (4440)
Michigan (239)
Minnesota (280)
Mississippi (5)
Missouri (86)
Montana (18)
Nebraska (10)
Nevada (63)
New Hampshire (59)
New Jersey (1948)
New Mexico (18)
New York (1551)
North Carolina (821)
North Dakota (8)
Northern California (2734)
Ohio (209)
Oklahoma (7)
Oregon (14)
Pennsylvania (1211)
Puerto Rico (12)
Rhode Island (23)
South America (497)
South Carolina (18)
Southern California (2188)
Tennessee (82)
Texas (743)
United States (20929)
Utah (142)
Virginia (121)
Washington D.C. (41)
Washington State (433)
West Virginia (2)
Wisconsin (64)
Wyoming (2)
314,579 Results for "nano global".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Curiteva Receives FDA Nano Designation for Inspire 3D Printed Trabecular PEEK Technology
January 19, 2026
·
2 min read
Press Releases
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
February 6, 2026
·
2 min read
Press Releases
Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
December 3, 2025
·
11 min read
Press Releases
Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
September 24, 2025
·
2 min read
Press Releases
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101' on Gastric Cancer.
December 24, 2025
·
3 min read
Press Releases
Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
December 5, 2025
·
11 min read
Press Releases
Revium Rx Advances Toward Phase 1 Clinical Development of Nano-Mupirocin to Combat Antibiotic-Resistant Infections
October 22, 2025
·
5 min read
Press Releases
Beautinelle Launches BeneLift Pro: A Groundbreaking FDA-Approved Nano Infusion Device
October 20, 2025
·
2 min read
Press Releases
Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
December 3, 2025
·
2 min read
Press Releases
Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing
December 4, 2025
·
10 min read
1 of 31,458
Next
